# A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

> **NCT01468467** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 13 (actual)

## Conditions studied

- Leukemia, Myeloid, Acute

## Interventions

- **DRUG:** AC220

## Key facts

- **NCT ID:** NCT01468467
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2019-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468467, "A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01468467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*